HACE1 inhibits the progression of a variety of tumors, including breast cancer, lung cancer, prostate cancer, and osteosarcoma, by regulating the ubiquitination and proteasomal degradation of Rac1. This evidence concerns the gene RAC1 and Familial prostate cancer.